Clinical Trial Update: Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers Phase 1/2 testing of allogeneic virus-specific cytotoxic T-lymphocytes for adenovirus and Epstein-Barr virus infections. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection
• Epstein-barr Virus Infection

Drugs mentioned

• Allogeneic virus-specific cytotoxic T-lymphocytes (virus-specific cytotoxic T-lymphocytes)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Adenovirus Infection, EBV Infection | Phase 1, Phase 2 | Status: COMPLETED